High-fat ketogenic diet may help protect the aging brain, research suggests

A growing body of research suggests that a high-fat, low-carbohydrate ketogenic diet (keto diet) may offer protective effects against neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, and ALS.

A recent review published in Translational Neurodegeneration examines studies from the past 15 years and concludes that the keto diet may influence brain health primarily by improving how the body generates and uses energy.

Under normal conditions, brain cells rely on glucose as their main fuel source. However, in many neurodegenerative diseases, glucose metabolism becomes impaired. The ketogenic diet shifts metabolism toward fat utilization, prompting the liver to produce ketone bodies—such as beta-hydroxybutyrate (BHB), acetoacetate, and acetone—which can serve as an alternative energy source for the brain.

These ketones help sustain neuronal energy supply, potentially supporting cellular repair and protective mechanisms. The diet may also beneficially alter the gut microbiome by reducing inflammation-associated bacteria while promoting microbial populations linked to improved intestinal barrier function.

Neurodegenerative diseases share common pathological features, including mitochondrial dysfunction, chronic inflammation, and oxidative stress, all of which contribute to progressive neuronal damage and cell death. The review suggests that ketone metabolism may counteract some of these processes.

Originally developed in 1921 by physician Russell Morse Wilder as a treatment for drug-resistant epilepsy, the ketogenic diet has since attracted interest as a potential therapeutic strategy for progressive neurological disorders. While current treatments mainly address symptoms rather than disease progression, the keto diet is being studied for its broader biological effects.

Beyond serving as an alternative fuel source, ketones may activate autophagy—the body’s cellular “cleanup” process—helping remove damaged proteins and dysfunctional cellular components associated with neurodegeneration. They may also reduce oxidative stress and dampen chronic inflammation in the brain.

Clinical findings, though still limited, report potential benefits. Patients with Alzheimer’s disease have shown improvements in memory, daily functioning, and quality of life. Individuals with Parkinson’s disease have reported increased energy, reduced fatigue, and better motor control. Similar trends have been observed in other neurological conditions.

However, researchers caution that adherence to the diet can be difficult due to its restrictive nature, and some individuals experience side effects such as fatigue, headaches, nausea, and dizziness during the initial adaptation phase, commonly referred to as the “keto flu.”

Overall, the review highlights the ketogenic diet as a promising but still experimental approach to supporting brain health in neurodegenerative disease. While early evidence is encouraging, further long-term clinical studies are needed to determine its safety, effectiveness, and practical use in medical settings.

Follow NEWS.am Medicine on Facebook and Twitter